In the BioHarmony Drug Report Database

"Preview" Icon

Eteplirsen

Exondys (eteplirsen) is an oligonucleotide pharmaceutical. Eteplirsen was first approved as Exondys on 2016-09-19. It is used to treat duchenne muscular dystrophy in the USA. Exondys 51’s patents are valid until 2034-03-14 (FDA).

 

Trade Name

 

Exondys
 

Common Name

 

eteplirsen
 

ChEMBL ID

 

CHEMBL2108278
 

Indication

 

duchenne muscular dystrophy
 

Drug Class

 

Antisense oligonucleotides

Image (chem structure or protein)

Eteplirsen structure rendering